Flagship Harbor Advisors’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$442K Buy
2,349
+2,099
+840% +$404K 0.02% 504
2025
Q4
$47.3K Buy
+250
New +$46.3K ﹤0.01% 1082
2025
Q3
Sell
-2,460
Closed -$377K 807
2025
Q2
$377K Buy
2,460
+281
+13% +$41.9K 0.02% 551
2025
Q1
$343K Buy
2,179
+195
+10% +$31.7K 0.02% 532
2024
Q4
$311K Buy
1,984
+214
+12% +$36K 0.02% 566
2024
Q3
$314K Sell
1,770
-33
-2% -$5.86K 0.02% 543
2024
Q2
$304K Buy
1,803
+114
+7% +$18.6K 0.02% 536
2024
Q1
$281K Buy
+1,689
New +$280K 0.02% 541
2020
Q4
Sell
-250
Closed -$40K 645
2020
Q3
$40K Hold
250
0.01% 915
2020
Q2
$40K Hold
250
0.01% 912
2020
Q1
$32K Hold
250
0.01% 877
2019
Q4
$35K Hold
250
0.01% 916
2019
Q3
$29K Hold
250
0.01% 949
2019
Q2
$32K Hold
250
0.01% 897
2019
Q1
$32K Hold
250
0.01% 891
2018
Q4
$27K Hold
250
0.01% 899
2018
Q3
$34K Hold
250
0.01% 936
2018
Q2
$29K Buy
+250
New +$29.5K 0.01% 970

Other funds holding BBH

Flagship Harbor Advisors's BBH Position: Q1 2026 in Review

Flagship Harbor Advisors increased its VanEck Biotech ETF (BBH) stake by 840% in Q1 2026, buying an estimated $404K and bringing the position to 2,349 shares worth $442K. The position accounts for 0.02% of the portfolio, ranked #504.

Flagship Harbor Advisors first reported a position in BBH in Q2 2018 and has held it in 18 quarters since. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • Flagship Harbor Advisors held 2,349 shares of VanEck Biotech ETF worth $442K as of Q1 2026.
  • Flagship Harbor Advisors bought 2,099 VanEck Biotech ETF shares in Q1 2026, an estimated $404K.
  • VanEck Biotech ETF made up 0.02% of Flagship Harbor Advisors's portfolio in Q1 2026, its #504 holding.
  • Flagship Harbor Advisors first reported a position in VanEck Biotech ETF in Q2 2018 and has held it in 18 quarters since.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.